A detailed history of Burns J W & CO Inc transactions in Eli Lilly & CO stock. As of the latest transaction made, Burns J W & CO Inc holds 3,475 shares of LLY stock, worth $2.72 Million. This represents 0.4% of its overall portfolio holdings.

Number of Shares
3,475
Previous 3,701 6.11%
Holding current value
$2.72 Million
Previous $3.35 Million 8.12%
% of portfolio
0.4%
Previous 0.45%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 04, 2024

SELL
$772.14 - $960.02 $174,503 - $216,964
-226 Reduced 6.11%
3,475 $3.08 Million
Q2 2024

Jul 23, 2024

BUY
$724.87 - $909.04 $90,608 - $113,630
125 Added 3.5%
3,701 $3.35 Million
Q3 2022

Oct 04, 2022

BUY
$296.48 - $337.87 $763,732 - $870,353
2,576 Added 257.6%
3,576 $1.16 Million
Q2 2021

Jul 12, 2021

BUY
$180.55 - $233.54 $180,550 - $233,540
1,000 New
1,000 $230,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $744B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Burns J W & CO Inc Portfolio

Follow Burns J W & CO Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Burns J W & CO Inc, based on Form 13F filings with the SEC.

News

Stay updated on Burns J W & CO Inc with notifications on news.